共 14 条
[1]
Adrenergic nervous system in heart failure. Esler M,Kaye D,Lambert G,et al. The American Journal of Cardiology . 1997
[2]
Meta analysisofeffectofbeta blockertherapyonmor talityinpatientswithNewYorkHeartAssociationclassⅣchroniccongestiveheartfailure. Whorlow,SL,KrumH. The American Journal of Cardiology . 2000
[3]
Effectsofcarvedilol,avasodialtorβ bloker,inpatientswithcongestiveheartduetoischemicheartdisease. AustraliaNewZealandheartfailureresearchcollaborativegroup. Circulation . 1995
[4]
Mechanism of action of beta-blocking agent in heart failure. Bristow MR. The American Journal of Cardiology . 1997
[5]
TheCardiacinsufficiencybisoprololstudyⅡ (CIBISⅡ):arandomizedtrial. CIBISⅡincestigatorsandcommitters. The Lancet . 1999
[6]
Beneficial of metoprolol in idiopathic dilated cardiomyopathy. Waagstein F,Bristow MR Swedberg K,et al. The Lancet . 1993
[7]
for the US carvedilol heart failure study group.The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. Packer M,Bristow M,Cohn J,et al. The New England Journal of Medicine . 1996
[8]
Effect of carvedilol on survival in sever chronic heart failure. Packer M,Coats AJS,Flower MB,et al. The New England Journal of Medicine . 2001
[9]
Double-blind place bocontrolled study of the effect of carvedilol in PRECISE trial. Packer M,Colucci WS,Sacker-Bernstein JD,et al. Circulation . 1996
[10]
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure.US Carvediolo Heart Failure Study Group. Colucci WS,Packer M,Bristow MR,et al. Circulation . 1996